United States · FDA National Drug Code directory
D-33
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58264-0033_2b9eb825-2e83-846c-e063-6394a90a0a7b
- Product NDC
- 58264-0033
- Form
- SOLUTION
- Composition / generic term
- ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC
- Labeler
- DNA Labs, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 19900101
- Source listing expiry
- 20261231
Source-listed ingredients
- ATROPA BELLADONNA — 30 [hp_X]/mL
- BUFO BUFO CUTANEOUS GLAND — 200 [hp_X]/mL
- COPPER — 12 [hp_X]/mL
- ANEMONE PRATENSIS — 30 [hp_X]/mL
- SILICON DIOXIDE — 30 [hp_X]/mL
- ZINC — 12 [hp_X]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 29.57 mL in 1 BOTTLE, GLASS (58264-0033-1) · 58264-0033-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →